CUSIX
Price
$15.67
Change
+$0.02 (+0.13%)
Updated
Aug 21 closing price
Net Assets
10.01M
DFSVX
Price
$63.03
Change
+$0.47 (+0.75%)
Updated
Aug 21 closing price
Net Assets
19.68B
Interact to see
Advertisement

CUSIX vs DFSVX

CUSIX vs DFSVX Comparison Chart in %
View a ticker or compare two or three
VS
CUSIX vs. DFSVX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CUSIX is a Hold and DFSVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.7B vs. CUSIX (10M). DFSVX pays higher dividends than CUSIX: DFSVX (1.50) vs CUSIX (1.28). CUSIX was incepted earlier than DFSVX: CUSIX (17 years) vs DFSVX (34 years). CUSIX (4.22) is less costly to investors than DFSVX (0.31). CUSIX is a more actively managed with annual turnover of: 38.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than CUSIX: DFSVX (0) vs CUSIX (1000000). DFSVX annual gain was more profitable for investors over the last year : 31.52 vs. CUSIX (13.15). DFSVX return over 5 years is better than : 54.66 vs. CUSIX (7.20).
CUSIXDFSVXCUSIX / DFSVX
Total Expense Ratio1.000.31323%
Annual Report Gross Expense Ratio4.220.311,361%
Fund Existence17 years34 years-
Gain YTD13.72523.03460%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets10M19.7B0%
Annual Yield % from dividends1.281.5085%
Returns for 1 year13.1531.5242%
Returns for 3 years27.6061.3245%
Returns for 5 years7.2054.6613%
Returns for 10 years34.34101.8534%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX23.980.24
+1.01%
Saratoga Health & Biotechnology A
GQJIX12.860.08
+0.63%
GQG Partners Intl Qual Val Fd Ins
DMCFX32.440.17
+0.53%
Invesco Discovery Mid Cap Growth R5
GRMIX34.660.15
+0.43%
Nationwide S&P 500 Index R6
TNXIX23.190.09
+0.41%
1290 Avantis U.S. Large Cap Growth I